Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Roche buys US Foundation Medicine for 2.4 billion dollar

      Roche buys US Foundation Medicine for 2.4 billion dollar

      Ruby Khatun Khatun22 Jun 2018 9:45 AM IST
      Geneva: Swiss pharmaceutical giant Roche said it had reached an agreement to purchase the remaining shares of US lab Foundation Medicine, of which it...
      Unjustified medication shortened 456 lives in a UK hospital, report says

      Unjustified medication shortened 456 lives in a UK hospital, report says

      Ruby Khatun Khatun22 Jun 2018 9:30 AM IST
      GOSPORT, England: More than 450 patients died prematurely in a British hospital after they were given powerful painkillers with no medical...
      Spurious Drugs Issue: DCGI Invites Top Pharma Brands on 25th June

      Spurious Drugs Issue: DCGI Invites Top Pharma Brands on 25th June

      Ruby Khatun Khatun21 Jun 2018 5:17 PM IST
      New Delhi: Through a recent notification, the Drug Controller General of India has invited manufacturers for a meeting on the introduction of trace...
      Cipla gets USFDA nod for generic HIV drug

      Cipla gets USFDA nod for generic HIV drug

      Ruby Khatun Khatun21 Jun 2018 3:23 PM IST
      New Delhi: Drug major Cipla said it has received approval from the US health regulator to market Efavirenz tablets, used to treat HIV-1 infections in...
      Zydus Cadila gets USFDA nod for erectile dysfunction drug

      Zydus Cadila gets USFDA nod for erectile dysfunction drug

      Ruby Khatun Khatun21 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used to erectile...
      Unichem enters settlement pact with Eli Lilly, ICOS Corp for erectile dysfunction drug

      Unichem enters settlement pact with Eli Lilly, ICOS Corp for erectile dysfunction drug

      Ruby Khatun Khatun21 Jun 2018 10:15 AM IST
      New Delhi: Unichem Laboratories said it has entered into a settlement pact with pharma major Eli Lilly & Company and ICOS Corporation for...
      USFDA approves first product from Glenmarks US plant

      USFDA approves first product from Glenmark's US plant

      Ruby Khatun Khatun21 Jun 2018 10:00 AM IST
      New Delhi: Glenmark Pharmaceuticals said the US health regulator has approved the first product from its Monroe, North Carolina based manufacturing...
      Latecomer Sanofi looks to catch next wave of cancer therapies

      Latecomer Sanofi looks to catch next wave of cancer therapies

      Ruby Khatun Khatun21 Jun 2018 9:45 AM IST
      PARIS: Sanofi missed the boat on immune system-boosting cancer drugs. Now it’s trying to catch up.The French drugmaker has hired John Reed, the former...
      Roche SMA drug shines in study as costly new therapies advance

      Roche SMA drug shines in study as costly new therapies advance

      Ruby Khatun Khatun21 Jun 2018 9:30 AM IST
      ZURICH: A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic...
      Marketing of unapproved drugs: Amendment in Act aimed to hold Pharma Giants Responsible

      Marketing of unapproved drugs: Amendment in Act aimed to hold Pharma Giants Responsible

      Ruby Khatun Khatun20 Jun 2018 4:25 PM IST
      New Delhi: Pharmaceutical companies, including the big ones are now under the radar of the central government which is planning to crack down on all...
      Dr Reddys launches generic epilepsy drug in US

      Dr Reddy's launches generic epilepsy drug in US

      Ruby Khatun Khatun20 Jun 2018 10:30 AM IST
      New Delhi: Dr Reddy's Laboratories said it has launched Levetiracetram in Sodium Chloride injection, an anti-epileptic drug, in the US market.The...
      Strides Shasun gets USFDA nod for generic anti-fungal drug

      Strides Shasun gets USFDA nod for generic anti-fungal drug

      Ruby Khatun Khatun20 Jun 2018 10:15 AM IST
      New Delhi: Drug firm Strides Shasun said it has received approval from the US health regulator to market Ketoconazole tablets, used to treat fungal...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok